Luwen Mu

Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma

Ning Lyu, Yanan Kong, Luwen Mu et al. · Journal of Hepatology · 2018 · 304 citations

Medicine, Oncology, Pharmacology +13

Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma

Haijing Deng, Anna Kan, Ning Lyu et al. · Liver Cancer · 2020 · 177 citations · Full text

Medicine, Immunology, Oncology +17

Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma

Qiankun Xie, Yujie Zhao, Tao Pan et al. · OncoImmunology · 2016 · 61 citations · Full text

Medicine, Immunology, Oncology +17

Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study

Ning Lyu, Yanan Kong, Xiaoxian Li et al. · Frontiers in Oncology · 2020 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study

Tao Pan, Luwen Mu, Chun Wu et al. · Journal of Cancer · 2017 · 55 citations · Full text

Medicine, Oncology, Surgery +15